Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-10-12
|
pubmed:abstractText |
The ability to identify and expand effector cells with reactivity against tumor-associated antigens (TAA) is critical for effective adoptive cellular therapy. The purpose of this study was to assess lymph node lymphocytes sensitized in vivo to the shed TAA TAG-72 as a potential source of cells for adoptive cellular therapy. Lymph nodes containing microscopic tumor and/or shed TAG-72+ mucin were localized using radiolabeled CC49 monoclonal antibody and a gamma detector at the time of exploratory colorectal surgery. Lymph nodes containing microscopic tumor and shed mucin exhibited approximately 40-fold expansion in short-term (< 21 days) cultures with either IL-2 or IL-1 plus IL-2; the combination of IL-2/anti-CD3 monoclonal antibody (mAb) resulted in significantly higher expansion. Cultures generated with IL-2 alone favored the expansion of CD8+ and CD56+ cells, whereas addition of IL-1 or anti-CD3 mAb to IL-2 promoted outgrowth of CD4+ T-cells. The IL-2/anti-CD3 expanded cells exhibited low levels of cytolytic activity in vitro against autologous and allogeneic colon tumor targets. However, CD4+ cells expanded in IL-2/anti-CD3 retained the ability to proliferate in response to TAG-72 mucin-expressing autologous tumor as well as bovine submaxillary mucin (BSM) a soluble TAG-72+ mucin. In addition, CD4+ cells expressed mRNA for IL-2, IL-4, tumor necrosis factor-beta and IFNg, and retained the ability to secrete IL-2 after expansion. Thus, noncytolytic, cytokine-secreting, mucin-reactive T- cells can be expanded from lymph nodes of patients with colorectal cancer.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Mucins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/tumor-associated antigen 72
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1062-8401
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-23
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7663570-Antigens, Neoplasm,
pubmed-meshheading:7663570-CD4-CD8 Ratio,
pubmed-meshheading:7663570-Colorectal Neoplasms,
pubmed-meshheading:7663570-Cytotoxicity, Immunologic,
pubmed-meshheading:7663570-Glycoproteins,
pubmed-meshheading:7663570-Humans,
pubmed-meshheading:7663570-Immunotherapy, Adoptive,
pubmed-meshheading:7663570-Interleukin-2,
pubmed-meshheading:7663570-Lymph Nodes,
pubmed-meshheading:7663570-Mucins,
pubmed-meshheading:7663570-Phenotype,
pubmed-meshheading:7663570-RNA, Messenger,
pubmed-meshheading:7663570-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:7663570-Tumor Cells, Cultured
|
pubmed:year |
1995
|
pubmed:articleTitle |
Expansion of mucin-reactive T-helper lymphocytes from patients with colorectal cancer.
|
pubmed:affiliation |
Department of Surgery, Ohio State University Comprehensive Cancer Center, Columbus, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|